Rare diseases
Investigational molecules
Locations
Back to Germany1 286 clinical trials in Aachen, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study on Atezolizumab and Chemotherapy for Patients with Triple-Negative Breast Cancer
GermanyStudy on the Long-term Effects of EDG-5506 for Adults and Adolescents with Becker Muscular Dystrophy
GermanyStudy Comparing Pembrolizumab and Chemotherapy for Patients with Advanced or Recurrent Endometrial Cancer
GermanyStudy on the Effectiveness and Safety of Ocrelizumab, Methylprednisolone, and Diphenhydramine Hydrochloride in Patients with Multiple Sclerosis
BelgiumStudy Comparing SGN-B6A and Docetaxel for Adults with Previously Treated Non-Small Cell Lung Cancer
GermanyStudy on the Effectiveness and Safety of CAM2029 Compared to Octreotide and Lanreotide in Patients with Gastroenteropancreatic Neuroendocrine Tumors
GermanyStudy on the Effects of Zalunfiban for Patients with ST-Elevation Myocardial Infarction (Heart Attack)
CzechiaStudy on the Safety of Human Serum Albumin and Enoxaparin in Patients with Decompensated Cirrhosis at High Risk of Poor Outcome
GermanyStudy Comparing Short-Course Radiotherapy and Drug Combination for Older Patients with Locally Advanced Rectal Cancer
BelgiumStudy on Lenalidomide, Tafasitamab, and Rituximab for Treating Diffuse Large B-Cell Lymphoma in Patients Aged 80 and Older
BelgiumStudy of Tafasitamab, Lenalidomide, and Rituximab for Patients with Relapsed or Refractory Follicular or Marginal Zone Lymphoma
GermanyStudy on Giredestrant and Fulvestrant with CDK4/6 Inhibitor for Patients with ER+ HER2-Negative Advanced Breast Cancer Resistant to Endocrine Therapy
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on lymphoma treatments and various forms of breast cancer therapies, including studies of novel immunotherapy combinations for head and neck cancers.
Advanced therapeutic approaches including targeted treatments and combination therapies are being evaluated for improved patient outcomes.
Research targeting heart failure prevention and management of cardiovascular complications, with emphasis on innovative drug combinations and preventive treatments.
Studies focus on reducing cardiovascular events and improving long-term patient outcomes.
Clinical investigations addressing various chronic conditions, including inflammatory diseases and dermatological disorders.
Evaluating new therapeutic approaches for managing long-term conditions and improving quality of life.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
